HOME >> BIOLOGY >> NEWS
Salmonella Vaccine Now Available For Poultry

A vaccine invented by a biologist at Washington University in St. Louis has received federal approval for use in controlling Salmonella bacteria in poultry.

Megan Health Inc., a St. Louis based vaccine discovery company, has been granted a United States Department of Agriculture (USDA) license for a vaccine that controls Salmonella contamination of poultry products.

The new vaccine, Megan™Vac 1, is applied to baby chicks via spray in the hatchery. The vaccine stimulates immunity in the chickens, preventing Salmonella infection during the growing period which may result in contamination and subsequent food borne infection of humans.

In recently completed trials on US commercial broiler farms which included more than a million pounds of chicken, Megan™Vac 1 eliminated Salmonella on dressed chicken. Ten percent of the non-vaccinated chickens in these trials were contaminated.

The US broiler chicken industry has improved their processed chicken contamination rate greatly in the past few years moving from 50% positive in the 1980's to 20% positive two years ago to 10% this past year (according to tests reported by USDA's Food Safety Inspection Service). " Our new vaccine is a remarkable tool which will help broiler producers reach their goal of 0 % contamination." says David Zacek, President of Megan Health Animal Health Division.

The new vaccine, more than 4.5 years in development, is the invention of Roy Curtiss III, Ph.D., professor of biology at Washington University and founder of Megan Health, Inc.

"This vaccine is designed to live only long enough to stimulate an immune response in chickens and then is eliminated by the chickens' immune system to assure food safety at processing. It is very specific for Salmonella control, very low cost at less than one cent per bird and is easily applied using traditional techniques now used by US broiler chicken production companies." according to Sandra Kelly, MS, Biologicals Deve
'"/>

Contact: Tony Fitzpatrick
tony_fitzpatrick@aismail.wustl.edu
314-935-5272
Washington University in St. Louis
3-Dec-1998


Page: 1 2

Related biology news :

1. Salmonella infects cells and saves itself by altering host membrane lipids
2. Salmonella uses molecular staples to change structure of infected cells
3. Vion Demonstrates Readiness Of First Tumor-Targeting Salmonella For Human Testing Against Solid Tumors
4. Researchers Identify Key Gene That Controls Emergence Of Salmonella
5. DT104 Advice:How To Slow Salmonella Spread
6. First Salmonella Vaccine For Poultry To Be On The Market Soon
7. Hope Clinic of Emory Vaccine Center receives CDC contract
8. Vaccines against foodborne disease on horizon
9. GenVec, U.S. NMRC, and PATHs Malaria Vaccine Initiative partner to expand malaria vaccine efforts
10. Vaccine technique shows potential against common form of lung cancer
11. Fighting fire with fire? Vaccine based on chimp virus shows promise against HIV

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/6/2017)... May 5, 2017 RAM Group ... a new breakthrough in biometric authentication based on ... mechanical properties to perform biometric authentication. These new sensors ... material created by Ram Group and its partners. This ... transportation, supply chains and security. Ram Group is ...
(Date:4/13/2017)... 13, 2017 UBM,s Advanced Design and Manufacturing ... feature emerging and evolving technology through its 3D Printing ... run alongside the expo portion of the event and ... demonstrations focused on trending topics within 3D printing and ... manufacturing event will take place June 13-15, 2017 at the ...
(Date:4/11/2017)... NXT-ID, Inc. (NASDAQ:   NXTD ) ("NXT-ID" or ... independent Directors Mr. Robin D. Richards and Mr. ... the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive Officer said," ... and benefiting from their considerable expertise as we move forward ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... Bay, Florida (PRWEB) , ... October 11, 2017 ... ... and Drug Administration (FDA) has granted orphan drug designation to SBT-100, its novel ... (sdAb) for the treatment of osteosarcoma. SBT-100 is able to cross the cell ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... program has won a US2020 STEM Mentoring Award. Representatives of the FirstHand program ... in Volunteer Experience from US2020. , US2020’s mission is to change the trajectory ...
(Date:10/10/2017)... , Oct. 10, 2017 SomaGenics announced ... the NIH to develop RealSeq®-SC (Single Cell), expected to ... profiling small RNAs (including microRNAs) from single cells using ... highlights the need to accelerate development of approaches to ... "New techniques for measuring levels of ...
(Date:10/9/2017)... , Oct. 9, 2017  BioTech Holdings ... mechanism by which its ProCell stem cell therapy ... limb ischemia.  The Company, demonstrated that treatment with ... of limbs saved as compared to standard bone ... molecule HGF resulted in reduction of therapeutic effect.  ...
Breaking Biology Technology:
Cached News: